The results suggested that the methylation level of ACADS in normal tissues was significantly higher than that in tumor tissues, indicating that it is possible to influence the methylation of ACADS to change its gene expression to inhibit the development of CRC and improve the prognosis of CRC patients. This evidence concerns the gene ACADS and neoplasm.